Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06189703 · ClinicalTrials.gov registry record · NA
tRNS Treatment for ADHD Symptoms
A NA study of ADHD, sponsored by Innosphere.
- Active
- Registry status
- NA
- Development phase
- 146
- Enrollment target
- 5
- Study locations
NCT06189703 is a NA study of ADHD that is active but no longer recruiting, run by Innosphere. The registered enrollment target is 146 participants, below the 188-participant average among 75 other ADHD trials with a reported enrollment target (22% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT06189703, a NA study of ADHD, is active but no longer recruiting, sponsored by Innosphere.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
- 5
- Study locations
Study Summary
A randomized, sham-controlled, double-blind clinical trial to examine the safety and effectiveness of tRNS on unmedicated pediatric patients (7-12 years) with ADHD. Subjects will undergo either tRNS or sham treatment for 10 days during a two-week period in a home-simulated environment. Each treatment session is 20 minutes, during which their attention will be maintained using a software game.
Conditions Studied
Interventions
- DEVICE tRNS
Study Locations (5)
Texas
- Baylor College of Medicine Department of Psychiatry & Behavioral Sciences - Houston
- UTHealth Houston - Houston
Massachusetts
- Boston Children's Hospital - Boston
Minnesota
- Mayo Clinic Hospital, Methodist Campus - Rochester
Other
- Hadassah Medical Center - Jerusalem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2024-07-15 |
| Est. Completion | 2026-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06189703
The ClinicalTrials.gov registry entry for NCT06189703 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 188-participant average among 75 other ADHD trials with a reported enrollment target (22% lower). The listed sponsor is Innosphere, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which tRNS is the first listed.
NCT06189703 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Texas, Massachusetts, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06189703 about?
NCT06189703 is a clinical study titled "tRNS Treatment for ADHD Symptoms". A randomized, sham-controlled, double-blind clinical trial to examine the safety and effectiveness of tRNS on unmedicated pediatric patients (7-12 years) with ADHD. Subjects will undergo either tRNS or sham treatment for 10 days during a two-week period in a home-simulated environment. Each treatmen...
What is the current status of trial NCT06189703?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 146 participants. The study started on 2024-07-15. Estimated completion is 2026-05-30.
What conditions does trial NCT06189703 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT06189703?
The interventions under investigation include: tRNS (DEVICE).
Who is sponsoring clinical trial NCT06189703?
This trial is sponsored by Innosphere, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06189703 being conducted?
This trial has 5 study locations across Massachusetts, Minnesota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Fidgeting and Attentional and Emotional Regulation in ADHD
RECRUITING · NA
-
Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study
RECRUITING · NA
-
A Pilot Study of a Remote ADHD Monitoring Program
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.